OWA
UTHR icon

One Wealth Advisors’s United Therapeutics UTHR Stock Holding History

One Wealth Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-105
Closed -$12K – 462
2019
Q1 		$12K Buy
+105
New +$12.2K 0.01% 309
2018
Q4 		– Sell
-569
Closed -$73K – 451
2018
Q3 		$73K Sell
569
-17
-3% -$2.1K 0.06% 230
2018
Q2 		$66K Hold
586
– – 0.05% 240
2018
Q1 		$66K Sell
586
-35
-6% -$4.45K 0.06% 228
2017
Q4 		$92K Buy
+621
New +$78.9K 0.07% 211

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

One Wealth Advisors's UTHR Position: Q2 2019 in Review

One Wealth Advisors sold out of United Therapeutics (UTHR) in Q2 2019, closing a stake of 105 shares — an estimated $12K sold.

One Wealth Advisors first reported a position in UTHR in Q4 2017 and held it in 5 quarters. The position peaked at $92K in Q4 2017. 320 funds tracked by Wall St. Rank hold UTHR as of Q2 2019.

  • One Wealth Advisors reported no remaining United Therapeutics position as of Q2 2019 after selling out during the quarter.
  • One Wealth Advisors sold 105 United Therapeutics shares in Q2 2019, an estimated $12K.
  • One Wealth Advisors first reported a position in United Therapeutics in Q4 2017 and held it in 5 quarters.
  • One Wealth Advisors's United Therapeutics position peaked at $92K in Q4 2017.
  • 320 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2019.

Based on One Wealth Advisors's 13F filing for Q2 2019, filed 14 Aug 2019.